Naratriptan Hennig (Naratriptan Hydrochloride)

Naratriptan works by selectively activating 5‑HT1B and 5‑HT1D receptors on cranial blood vessels and trigeminal nerve fibers. This activation causes vasoconstriction of dilated intracranial arteries and blocks the release of pain‑inducing neuropeptides, thereby reducing migraine pain.

The specific dose of Naratriptan Hennig is determined by the prescribing healthcare professional based on the individual patient's condition, medical history, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety of naratriptan in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To order Naratriptan Hennig, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Naratriptan has a relatively long half‑life compared with some other triptans, which can provide sustained migraine relief and may reduce the need for repeat dosing. Its side‑effect profile is similar to other agents in the class, but individual response can vary, so clinicians choose based on patient history and tolerability.

Naratriptan Hennig tablets should be stored at ambient temperature, preferably below 25 °C, in their original packaging to protect them from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Naratriptan Hennig is taken orally, usually as a tablet, with or without water. It is intended for use at the onset of a migraine attack. Patients should follow the dosing instructions provided by their prescriber and avoid taking more than the prescribed amount.

Serious risks include chest pain or tightness, coronary vasospasm, severe hypertension, and serotonin syndrome, especially when combined with other serotonergic drugs. Patients experiencing any of these symptoms should seek immediate medical attention.

Naratriptan Hennig is contraindicated in patients with uncontrolled hypertension, a history of coronary artery disease, recent stroke or transient ischemic attack, and in those taking MAO inhibitors or ergotamine derivatives. It should also be avoided in individuals with known hypersensitivity to naratriptan.